Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-051657
Date:2021-08-13
Issuer: ORIC PHARMACEUTICALS, INC. (ORIC)
Original Submission Date:

Reporting Person:

HOERTER STEVEN L.
C/O ORIC PHARMACEUTICALS, INC.
240 E. GRAND AVE., 2ND FLOOR SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 18.63 2021-08-13 deemed execution date A 33,250 (a) 2031-08-12 common stock 33,250 $18.63 33,250 direct
Footnotes
IDfootnote
f1 one thirty-sixth (1/36th) of the shares subject to the option shall vest on each monthly anniversary of august 13, 2021.
WhaleWisdom Logo

Elevate your investments